Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing
Chromosomal translocations and pathogenic nucleotide variants both gained special clinical importance in lymphoma diagnostics. Non-invasive genotyping from peripheral blood (PB) circulating free nucleic acid has been effectively used to demonstrate cancer-related nucleotide variants, while gene fusi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/12/3032 |
id |
doaj-a99aa3a817d243b4abcbc094987b75ef |
---|---|
record_format |
Article |
spelling |
doaj-a99aa3a817d243b4abcbc094987b75ef2021-07-01T00:25:50ZengMDPI AGCancers2072-66942021-06-01133032303210.3390/cancers13123032Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation SequencingAttila Mokánszki0Réka Bicskó1Lajos Gergely2Gábor Méhes3Department of Pathology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, HungaryDepartment of Hematology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, HungaryDepartment of Hematology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, HungaryDepartment of Pathology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, HungaryChromosomal translocations and pathogenic nucleotide variants both gained special clinical importance in lymphoma diagnostics. Non-invasive genotyping from peripheral blood (PB) circulating free nucleic acid has been effectively used to demonstrate cancer-related nucleotide variants, while gene fusions were not covered in the past. Our prospective study aimed to isolate and quantify PB cell-free total nucleic acid (cfTNA) from patients diagnosed with aggressive lymphoma and to compare with tumor-derived RNA (tdRNA) from the tissue sample of the same patients for both gene fusion and nucleotide variant testing. Matched samples from 24 patients were analyzed by next-generation sequencing following anchored multiplexed polymerase chain reaction (AMP) for 125 gene regions. Eight different gene fusions, including the classical <i>BCL2</i>, <i>BCL6</i>, and <i>MYC</i> genes, were detected in the corresponding tissue biopsy and cfTNA specimens with generally good agreement. Synchronous <i>BCL2</i> and <i>MYC</i> translocations in double-hit high-grade B-cell lymphomas were obvious from cfTNA. Besides, mutations of 29 commonly affected genes, such as <i>BCL2</i>, <i>MYD88</i>, <i>NOTCH2</i>, <i>EZH2</i>, and <i>CD79B</i>, could be identified in matched cfTNA, and previously described pathogenic variants were detected in 16/24 cases (66.7%). In 3/24 cases (12.5%), only the PB sample was informative. Our prospective study demonstrates a non-invasive approach to identify frequent gene fusions and variants in aggressive lymphomas. cfTNA was found to be a high-value representative reflecting the complexity of the lymphoma aberration landscape.https://www.mdpi.com/2072-6694/13/12/3032aggressive lymphomaliquid biopsycell-free nucleic acidgene fusionmutation analysisnext-generation sequencing (NGS) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Attila Mokánszki Réka Bicskó Lajos Gergely Gábor Méhes |
spellingShingle |
Attila Mokánszki Réka Bicskó Lajos Gergely Gábor Méhes Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing Cancers aggressive lymphoma liquid biopsy cell-free nucleic acid gene fusion mutation analysis next-generation sequencing (NGS) |
author_facet |
Attila Mokánszki Réka Bicskó Lajos Gergely Gábor Méhes |
author_sort |
Attila Mokánszki |
title |
Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing |
title_short |
Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing |
title_full |
Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing |
title_fullStr |
Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing |
title_full_unstemmed |
Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing |
title_sort |
cell-free total nucleic acid-based genotyping of aggressive lymphoma: comprehensive analysis of gene fusions and nucleotide variants by next-generation sequencing |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2021-06-01 |
description |
Chromosomal translocations and pathogenic nucleotide variants both gained special clinical importance in lymphoma diagnostics. Non-invasive genotyping from peripheral blood (PB) circulating free nucleic acid has been effectively used to demonstrate cancer-related nucleotide variants, while gene fusions were not covered in the past. Our prospective study aimed to isolate and quantify PB cell-free total nucleic acid (cfTNA) from patients diagnosed with aggressive lymphoma and to compare with tumor-derived RNA (tdRNA) from the tissue sample of the same patients for both gene fusion and nucleotide variant testing. Matched samples from 24 patients were analyzed by next-generation sequencing following anchored multiplexed polymerase chain reaction (AMP) for 125 gene regions. Eight different gene fusions, including the classical <i>BCL2</i>, <i>BCL6</i>, and <i>MYC</i> genes, were detected in the corresponding tissue biopsy and cfTNA specimens with generally good agreement. Synchronous <i>BCL2</i> and <i>MYC</i> translocations in double-hit high-grade B-cell lymphomas were obvious from cfTNA. Besides, mutations of 29 commonly affected genes, such as <i>BCL2</i>, <i>MYD88</i>, <i>NOTCH2</i>, <i>EZH2</i>, and <i>CD79B</i>, could be identified in matched cfTNA, and previously described pathogenic variants were detected in 16/24 cases (66.7%). In 3/24 cases (12.5%), only the PB sample was informative. Our prospective study demonstrates a non-invasive approach to identify frequent gene fusions and variants in aggressive lymphomas. cfTNA was found to be a high-value representative reflecting the complexity of the lymphoma aberration landscape. |
topic |
aggressive lymphoma liquid biopsy cell-free nucleic acid gene fusion mutation analysis next-generation sequencing (NGS) |
url |
https://www.mdpi.com/2072-6694/13/12/3032 |
work_keys_str_mv |
AT attilamokanszki cellfreetotalnucleicacidbasedgenotypingofaggressivelymphomacomprehensiveanalysisofgenefusionsandnucleotidevariantsbynextgenerationsequencing AT rekabicsko cellfreetotalnucleicacidbasedgenotypingofaggressivelymphomacomprehensiveanalysisofgenefusionsandnucleotidevariantsbynextgenerationsequencing AT lajosgergely cellfreetotalnucleicacidbasedgenotypingofaggressivelymphomacomprehensiveanalysisofgenefusionsandnucleotidevariantsbynextgenerationsequencing AT gabormehes cellfreetotalnucleicacidbasedgenotypingofaggressivelymphomacomprehensiveanalysisofgenefusionsandnucleotidevariantsbynextgenerationsequencing |
_version_ |
1721348652072435712 |